Search results
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 22 hours agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 3 days agoInvestors should also take note of any recent adjustments to analyst estimates for AbbVie. Recent...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 3 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
A company insider recently sold 21,082 shares of Abbvie Inc [ABBV]. Should You Sale? – Knox Daily
Knox Daily· 6 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Abbvie ...
AbbVie Inc. (NYSE:ABBV) Receives $176.14 Average PT from Brokerages
ETF DAILY NEWS· 2 days agoBMO Capital Markets decreased their target price on AbbVie from $195.00 to $180.00 and set an “outperform” rating on the stock in a report ...
AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than...
Hedge Fund Favorites: 7 Stocks to Buy When You're Feeling Jittery
InvestorPlace· 2 hours agoWith the market entering a historically challenging season (due to the adage buy in May and go...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 4 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
RBC recommends buying MindMed amid psychedelic stocks sell-off (NASDAQ:MNMD)
Seeking Alpha· 20 hours agoRBC Capital said it would be “buyers of weakness” in Mind Medicine (MNMD) shares following a...